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Introduction
The Wilms' tumor gene (WT1) consists of 10 exons that encode a zinc finger transcription factor involved in the genitourinary development during embryogenesis (1, 2) . Recently studies describe WT1 protein as an oncogene because is enveloped in cancer regulating genes responsible for cell growth, apoptosis and tumoral angiogenesis such as cyclin D1, Bcl-2, Bcl-xL, BFL1, c-myc, VEGF (3) (4) (5) (6) (7) (8) . The WT1 protein is conformed by an Nterminal protein region contains domain involved in transcriptional regulation, selfassociation, and RNA recognition (9) (10) (11) , and a C-terminal protein region that contains a DNA/RNA binding domain and consist in four zinc-finger that can bind to GC-rich sequences (12) (13) (14) .
WT1 gene shows two alternative splicing sites, identified as exon 5 or 17AA and other that occurs in the exon 9 and identified as KTS (Lys-Thr-Ser) (15) . The different isoforms are referred to as A) isoform that lacks both 17 amino acid and KTS inserts; B) isoform contains the 17 amino acid insert but lacks KTS insert; C) isoform lacks the 17 amino acid insert but contains KTS insert; and D) isoform contains both inserts (16, 17) .
Moreover, has three sites of initiation of translation that produces three isoforms of different molecular weight (62-64 kDa, 52-54 kDa and 36-38 kDa) with different biological properties (18, 19) . The 62-64 kDa WT1 protein isoform is not essential for normal development and reproduction in mice (20) and, the 36-38 kDa WT1 protein isoform has more oncogenic potential than WT1 52-54 kDa protein isoform in leukemia cells (20, 21) .
It is reported that WT1 appears to have a growth regulatory role in many solid cancers including lung (22) , colon (23) , pancreatic (24) , breast (25) , and gastric (26) , and no solid cancer as leukemia (27) , and lymphoma (28) . In breast cancer, Silberstein et al., 1997 initially considered to WT1 as a tumor suppressor gene, because its overexpression was found in healthy tissue and not in breast cancer tissue (29) (32) . Another work-related to tumor markers in breast cancer was performed by Tuna et al., 2005 , where they observe that the signaling pathway of Her2/neu through Akt it is possible to regulate the levels of WT1 expression, concluding that the WT1 protein plays a vital role in the regulation of cell cycle progression and apoptosis (33) .
Accordingly, due to the previous studies, we hypothesize that overexpression of WT1 and the change of isoforms allow WT1 to be present at different stages of breast cancer progression.
In this paper, were analyzed the expression of WT1 isoforms, ER and Her2/neu in a longterm estrogen depletion in vitro model, to mimic the malignant progression of breast cancer switch from estrogen-dependent to estrogen-independent growth. Long-Term Estrogen Depletion assay. MCF-7 cells were grown in DMEM/F12 culture medium supplemented with 10% FBS until 60% confluence, thereafter the cells were washed twice with sterile buffer PBS to eliminate the phenol red, and culture medium was replaced with DMEM/F12 phenol red-free supplemented with 10% of charcoal-dextran treated FBS manufactured by HyClone (Road Logan Utah, USA), the time of sampling were made according to cell growth.
Growth kinetics. The growth was performed seeding 2.5 x10 5 MCF-7 cells in a normal condition and MCF-7 LTED cells (27 weeks) per well in six wells plates using respective culture medium than were harvested at 24 and 72 hours and quantified by trypan blue exclusion staining. Each count was done by triplicate and the initial number of cells were considered as 1. 
Assays of MCF-7 LTED cells treated with

Results
WT1 protein isoforms expression in breast cancer cell lines
Initially, the characterization of the expression of the WT1 isoforms was carried out in Figure 1B) .
MCF-7 cells in short-term estrogen depletion increases the expression of 52-54 kDa
WT1 protein isoform.
To analyze the effects of estrogen depletion in the WT1 expression, several assays were carried out in the MCF-7 positive estrogen receptor cells. The MCF-7 cells cultured under normal conditions was changed to medium to conditions of estrogen depletion for 24 and 48 hours, then a western blot was performed. The expression of the 36-38 kDa WT1
protein isoform was not affected, however, the expression of the 52-54 kDa WT1 protein isoform was significantly increased (Figure 2A) . The expression of 36-38 kDa WT1 protein isoforms significantly increased during all the 27 weeks ( Figure 2B) .
MCF-7 cells in long-term estrogen depletion increases the expression
The low proliferation of MCF-7 cells cultured in long-term estrogen depletion
Growth kinetic was performed to compare the MCF-7 cells cultured in the medium under normal conditions against the MCF-7 LTED cells cultured for 27 weeks in culture medium with estrogen depletion. The assay was performed using the culture medium corresponding to each of the estrogen conditions. MCF-7 LTED cellular proliferation was significantly decreased (1.4 folds) (value p ≤ 0.05) in comparison with the MCF-7 cells cultivated under normal conditions (Figure 3A) .
Effect of tamoxifen on MCF-7 LTED cells
Subsequently, a tamoxifen sensitivity test was performed on the MCF-7 LTED cells ( (Figure 3B) . The MCF-7 LTED cells were much less sensitive to the anti-proliferative effect of tamoxifen.
Analysis of Her2/neu and Estrogen Receptor Expression in MCF-7 LTED cells.
To observe the behavior of the molecular markers Her2/neu and Estrogen Receptor a quantitative RT-PCR analysis was performed using samples of MCF-7 LTED cells taken in several times. The mRNA expression of Her2/neu and ER, significantly increased in MCF-7 LTED cells, that started from week 22 until week 53, was reported an increase of 2.98 (SD ± 0,43) and 2.59 (SD ± 0,99) expression levels of the markers Her2/neu and Estrogen Receptor, respectively (Figure 4 ).
Discussion
Breast cancer worldwide represents a major health problem, due to its high incidence and high mortality that occupies the second cause of cancer death in general, and the first cause of cancer death in women (35) . The molecular classification of breast cancer is performed to the tumor markers Progesterone receptor, Estrogen receptor and Her2/neu.
Estrogen receptor and Her2/neu are the most important tumor markers in breast cancer because their presence dictates the type of therapy to be followed and the prognosis of the disease (36, 37) . The critical step in malignant progression of breast cancer is the switch from estrogen-dependent to estrogen-independent growth (38) . During the change of hormonal dependence, the activity of Her2/neu is increased, relating it to a high metastatic potential (39) .
High expression of WT1 wild-type in breast cancer has been reported in > 90% (25, 30) , and high levels of the WT1 expression have been inversely associated with patient survival. The presence of WT1 is essential for breast cancer cell growth (32) , however, it
is still unclear what role it plays during the progression of breast cancer. WT1 can act as a tumor suppressor gene or as an oncogene, and this may be due to the presence of various isoforms which have different biological properties (40) .
The four isoforms are expressed in primary human solid cancers, including lung cancer (30) , HNSCC (41) sarcoma (42) , breast cancer (43) , and human primary leukemia (44) .
However, the functions of each of the four WT1 isoforms in cancer cells remain unclear (45) . In the present study, were analyzed the WT1 isoforms present in the breast cancer cell lines. In our results, were observed the presence of the 52-54 kDa WT1 isoform in Its presence has been determined in cell lines and specimens of the Wilms tumor where it has been reported that its transactivating function is 1.5 levels higher than the 52-54 kDa WT1 isoform KTS (-) (19) .
In order to the alternative splicing of WT1, we observe that MCF-7 cells presented the four isoforms ( There are currently few studies where the 36-38 kDa WT1 isoform is analyzed, so it is important to carry out a characterization of the WT1 isoforms in samples of breast cancer patients with various tumor marker status. Finally, we conclude that it is evident that the change of WT1 isoforms during depletion of estrogens in the MCF-7 cells plays a role in adapting to hormonal non-dependence. 
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